NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
2.390
-0.040 (-1.65%)
At close: Apr 28, 2026, 4:00 PM EDT
2.610
+0.220 (9.21%)
Pre-market: Apr 29, 2026, 7:29 AM EDT
NovaBridge Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
30
Market Cap
276.40M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cellectis | 79.59M |
| Compugen | 72.76M |
| Coherus Oncology | 42.17M |
| Editas Medicine | 40.52M |
| C4 Therapeutics | 35.95M |
| AC Immune | 4.51M |
| Artiva Biotherapeutics | 251.00K |
NBP News
- 7 days ago - NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value - GlobeNewsWire
- 21 days ago - NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer - GlobeNewsWire
- 7 weeks ago - Mid-Cap NovaBridge Biosciences Stock Jumps Fueled By Positive Study Data In Eye Disease - Benzinga
- 7 weeks ago - NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study - GlobeNewsWire
- 2 months ago - NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026 - GlobeNewsWire
- 2 months ago - NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference - GlobeNewsWire
- 2 months ago - NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform - GlobeNewsWire